Cargando…
No benefit of hydroxychloroquine in COVID-19: Results of Systematic Review and Meta-Analysis of Randomized Controlled Trials”()
BACKGROUND AND AIMS: Coronavirus pandemic is currently a global public health emergency with no definitive treatment guidelines. We conducted a systematic review and meta-analysis of the literature evaluating the efficacy of hydroxychloroquine and its related formulations in COVID-19 patients. METHO...
Autores principales: | Pathak, Dr Subodh Kumar, Salunke, Dr Abhijeet Ashok, Thivari, Dr Praveen, Pandey, Apurva, Nandy, Dr Kunal, Harish V K Ratna, Dr, Pandey, Dr Sanjay, Chawla, Dr Jasneet, Mujawar, Dr Jalil, Dhanwate, Dr Anant, Menon, Dr Vivek |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Diabetes India. Published by Elsevier Ltd.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7462641/ https://www.ncbi.nlm.nih.gov/pubmed/32905939 http://dx.doi.org/10.1016/j.dsx.2020.08.033 |
Ejemplares similares
-
Abstract #1185162: Association of the prognostic biomarkers for COVID-19 with grade of Hyperglycemia in T2DM with Mild to Moderate COVID-19 managed through Teleconsultations- A Two Center Cohort Study
por: Jaggi, Dr. Shalini, et al.
Publicado: (2022) -
ATLAS Muon Calibration Frameowrk
por: Carlino, Dr, et al.
Publicado: (2010) -
Complications after discharge with COVID-19 infection and risk factors associated with development of post-COVID pulmonary fibrosis
por: Aul, Dr Raminder, et al.
Publicado: (2021) -
A Prospective Survey to Understand the Preferences and Perspectives of Patients with Hematological Malignancies in a Tertiary Cancer Care Setting in India (CANCOV SURVEY)
por: Sharma, Dr. Neha, et al.
Publicado: (2021) -
Mucormycosis as a complication of Covid-19 – A case report
por: Raghu, Dr. Roshini, et al.
Publicado: (2021)